About the Journal
The Current Translational Medicine (CTM) is a peer-reviewed, open-access journal dedicated to advancing the field of translational medicine by bridging the gap between basic biomedical research and clinical application. Our mission is to facilitate the seamless integration of laboratory discoveries into evidence-based clinical practice, ultimately improving patient outcomes and public health.
CTM welcomes original research articles, reviews, case studies, and perspectives in the following areas:
- Preclinical and Clinical Research: Novel findings in molecular biology, genetics, pharmacology, and biomedical engineering that have direct implications for clinical practice.
- Biomarker Discovery & Precision Medicine: Identification and validation of biomarkers for disease diagnosis, prognosis, and treatment response.
- Drug Development & Therapeutics: Preclinical and early-phase clinical trials focusing on drug discovery, repurposing, and personalized medicine strategies.
- Regenerative Medicine & Stem Cell Research: Advances in cell-based therapies, tissue engineering, and regenerative approaches for disease treatment.
- Medical Devices & Digital Health: Innovations in diagnostics, wearable technologies, artificial intelligence, and telemedicine to enhance healthcare delivery.
- Public Health & Health Policy: Translational research with implications for healthcare systems, health equity, and policy-making.
- Immunotherapy & Vaccine Development: Breakthroughs in immunology, cancer immunotherapy, and novel vaccine strategies.
CTM serves a diverse readership, including biomedical researchers, clinicians, healthcare professionals, pharmaceutical and biotechnology experts, and policymakers involved in the development and implementation of translational medicine.
We are committed to fostering open scientific exchange through a rigorous peer-review process, ensuring high-quality and impactful research contributions. The journal publishes articles on a rolling basis, promoting rapid dissemination of significant findings in translational medicine.






